Coradduzza Donatella, Garroni Giuseppe, Congiargiu Antonella, Balzano Francesca, Cruciani Sara, Sedda Stefania, Nivoli Alessandra, Maioli Margherita
Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.
Int J Mol Sci. 2022 Sep 10;23(18):10489. doi: 10.3390/ijms231810489.
Bipolar disorder (BD) is a severe, chronic, and disabling neuropsychiatric disorder characterized by recurrent mood disturbances (mania/hypomania and depression, with or without mixed features) and a constellation of cognitive, psychomotor, autonomic, and endocrine abnormalities. The etiology of BD is multifactorial, including both biological and epigenetic factors. Recently, microRNAs (miRNAs), a class of epigenetic regulators of gene expression playing a central role in brain development and plasticity, have been related to several neuropsychiatric disorders, including BD. Moreover, an alteration in the number/distribution and differentiation potential of neural stem cells has also been described, significantly affecting brain homeostasis and neuroplasticity. This review aimed to evaluate the most reliable scientific evidence on miRNAs as biomarkers for the diagnosis of BD and assess their implications in response to mood stabilizers, such as lithium. Neural stem cell distribution, regulation, and dysfunction in the etiology of BD are also dissected.
Int J Mol Sci. 2022-9-10
Int J Mol Sci. 2023-6-13
Acta Psychiatr Scand. 2018-6-3
Brain Res Rev. 2009-10
Acta Psychiatr Scand. 2012-6-8
Biomedicines. 2025-2-18
Front Psychiatry. 2025-1-7
Neuropsychopharmacol Rep. 2024-3
Microorganisms. 2023-8-28
Int J Mol Sci. 2023-9-5
J Mol Diagn. 2022-11
Int J Mol Sci. 2022-6-20
Pharmacogenomics J. 2022-7
Int J Mol Sci. 2022-1-30
Transl Psychiatry. 2021-5-3
Biochim Biophys Acta Mol Basis Dis. 2020-12-1